http://dx.doi.org/10.31703/giidr.2019(IV-I).04
10.31703/giidr.2019(IV-I).04
Published : Dec 2019
Worldwide Epidemiology of Plasmodium Vivax Malaria and its Clinical Management
Plasmodium vivax malaria is one of the most common vector-borne parasitic infections worldwide. P. vivax clinical manifestations include lung injury, renal dysfunction, hepatic dysfunction and extreme thrombocytopenia etc. P. vivax contributes around 70% of malaria cases in Pakistan with variable severity, but 47% of total severe vivax malaria cases have been reported in India. Elimination of P. vivax is very difficult because of its ability to form dormant stages of the liver. Insecticidetreated nets and insecticides are used to control malaria in malaria-endemic regions. Chloroquine is used as the first line of the agent in P. vivax malaria treatment. ACTs are also very effective because of their fast medical and parasitological response than that of chloroquine. Due to increasing drug resistance among P. vivax, scientists have tested with mass drug administration to eradicate malaria. In spite of all this, the P. vivax vaccine would be the last resort in the eradication of P. vivax malaria.
-
Plasmodium Vivax, Malaria, Epidemiology, Long Incubation, P. Vivax Prevention, P. Vivax Treatment
-
(1) Iqra Riaz
Undergraduate Students, Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
(2) Mehek Muhammad
Undergraduate Students, Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
(3) Amina Bibi
Senior Chief Pharmacist, Federal Government Polyclinic Institute, Islamabad, Pakistan.
- Al-Awadhi, M., Ahmad, S., & Iqbal, J. (2021). Current Status and the Epidemiology of Malaria in the Middle East Region and Beyond. Microorganisms, 9(2), 338.
- Auburn, S., Cheng, Q., Marfurt, J., & Price, R. N. (2021). The changing epidemiology of Plasmodium vivax: Insights from conventional and novel surveillance tools. PLoS medicine, 18(4), e1003560.
- Baird, K. (2015). Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria. Pathogens and global health, 109(3), 93-106.
- Chu, C. S., & White, N. J. (2021). The prevention and treatment of Plasmodium vivax malaria. PLoS medicine, 18(4), e1003561.
- Douglas, N. M., Pontororing, G. J., Lampah, D. A., Yeo, T. W., Kenangalem, E., Poespoprodjo, J. R., & Price, R. N. (2014). Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia. BMC medicine, 12(1), 1-13.
- Joshi, H., Prajapati, S. K., Verma, A., Kang'a, S., & Carlton, J. M. (2008). Plasmodium vivax in India. Trends in parasitology, 24(5), 228-235.
- Kondrashin, A., Baranova, A. M., Ashley, E. A., Recht, J., White, N. J., & Sergiev, V. P. (2014). Mass primaquine treatment to eliminate vivax malaria: lessons from the past. Malaria journal, 13(1), 1-16.
- Lima-Junior, J. D. C., & Pratt-Riccio, L. R. (2016). Major Histocompatibility Complex and Malaria: Focus on Plasmodium vivax Infection. Frontiers in Immunology, 7. https://doi.org/10.3389/fimmu.2016.00013
- Lorenz von Seidlein, I. D. (2021). Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure.
- Mouchet, J. (1988). Agriculture and vector resistance. International Journal of Tropical Insect Science, 9(3), 297-302.
- Ngufor, C., Fagbohoun, J., Critchley, J., N'Guessan, R., Todjinou, D., Malone, D., & Rowland, M. (2017). Which intervention is better for malaria vector control: insecticide mixture long-lasting insecticidal nets or standard pyrethroid nets combined with indoor residual spraying? Malaria journal, 16(1), 1-9.
- Payne, R. O., Silk, S. E., Elias, S. C., Milne, K. H., Rawlinson, T. A., Llewellyn, D., & Draper, S. J. (2017). Human vaccination against Plasmodium vivax Duffy-binding protein induces strain- transcending antibodies. JCI insight, 2(12).
- Poespoprodjo, J. R., Fobia, W., Kenangalem, E., Lampah, D. A., Hasanuddin, A., Warikar, N., & Price, R. N. (2009). Vivax malaria: a major cause of morbidity in early infancy. Clinical Infectious Diseases, 48(12), 1704-1712.
- Protopopoff, N., Mosha, J. F., Lukole, E., Charlwood, J. D., Wright, A., Mwalimu, C. D., & Rowland, M. (2018). Effectiveness of a long-lasting piperonyl butoxide-treated insecticidal net and indoor residual spray interventions, separately and together, against malaria transmitted by pyrethroid-resistant mosquitoes: a cluster, randomized controlled, two-by-two factorial design trial. The Lancet, 391(10130), 1577- 1588.
- Pukrittayakamee, S., Vanijanonta, S., Chantra, A., Clemens, R., & White, N. J. (1994). Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. Journal of Infectious Diseases, 169(4), 932-935.
- Rahimi, B. A., Thakkinstian, A., White, N. J., Sirivichayakul, C., Dondorp, A. M., & Chokejindachai, W. (2014). Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900. Malaria journal, 13(1), 1-10.
- Smithuis, F., Kyaw, M. K., Phe, O., Win, T., Aung, P. P., Oo, A. P. P., & White, N. J. (2010). Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open- label randomized trial. The Lancet infectious diseases, 10(10), 673-681.
- World Health Organization. (2015). Guidelines for the treatment of malaria. World Health Organization. https://apps.who.int/iris/rest/bitstreams/71930 4/retrieve
Cite this article
-
APA : Riaz, I., Muhammad, M., & Bibi, A. (2019). Worldwide Epidemiology of Plasmodium Vivax Malaria and its Clinical Management. Global Immunological & Infectious Diseases Review, IV(I), 24-29. https://doi.org/10.31703/giidr.2019(IV-I).04
-
CHICAGO : Riaz, Iqra, Mehek Muhammad, and Amina Bibi. 2019. "Worldwide Epidemiology of Plasmodium Vivax Malaria and its Clinical Management." Global Immunological & Infectious Diseases Review, IV (I): 24-29 doi: 10.31703/giidr.2019(IV-I).04
-
HARVARD : RIAZ, I., MUHAMMAD, M. & BIBI, A. 2019. Worldwide Epidemiology of Plasmodium Vivax Malaria and its Clinical Management. Global Immunological & Infectious Diseases Review, IV, 24-29.
-
MHRA : Riaz, Iqra, Mehek Muhammad, and Amina Bibi. 2019. "Worldwide Epidemiology of Plasmodium Vivax Malaria and its Clinical Management." Global Immunological & Infectious Diseases Review, IV: 24-29
-
MLA : Riaz, Iqra, Mehek Muhammad, and Amina Bibi. "Worldwide Epidemiology of Plasmodium Vivax Malaria and its Clinical Management." Global Immunological & Infectious Diseases Review, IV.I (2019): 24-29 Print.
-
OXFORD : Riaz, Iqra, Muhammad, Mehek, and Bibi, Amina (2019), "Worldwide Epidemiology of Plasmodium Vivax Malaria and its Clinical Management", Global Immunological & Infectious Diseases Review, IV (I), 24-29
-
TURABIAN : Riaz, Iqra, Mehek Muhammad, and Amina Bibi. "Worldwide Epidemiology of Plasmodium Vivax Malaria and its Clinical Management." Global Immunological & Infectious Diseases Review IV, no. I (2019): 24-29. https://doi.org/10.31703/giidr.2019(IV-I).04